• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Grants
    • Partners
    • NCSG Bylaws
JOIN NOW
✕
Categories
  • Primary Sclerosing Cholangitis
Tags

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis

 

Study title A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Disease or condition Primary Sclerosing Cholangitis
Study type Interventional (clinical trial)
Intervention/treatment Volixibat (capsule)
Phase 2
Study site Duke University
Study location Durham, NC
Principal investigator Julius Wilder
Study coordinator name and email Adele Gaskin; adele.gaskin@duke.edu
Phone Contact 919-684-0742
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04663308

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN NOW